Epigenetics Market Overview:
According to the World Health Organization (WHO), cancer happens to be the second leading cause of deaths; a figure that translates to a staggering number of 9.6 million people who die out of cancer. Furthermore, the organization has found that one in six people die due to cancer each year. While this disquieting situation has become a major concern in the world, the healthcare sector is making remarkable investments in the research of the disease and the subsequent development of an effective drug that can cure the same. The most important aspect of cancer treatment is the diagnosis stage in which epigenetics plays an indispensable role. The growing concern pertaining to cancer is leading to lucrative growth prospects in the epigenetics market that had a market size of $1.15 billion as of 2018. Moreover, the demand for epigenetics in cancer diagnosis and other applications is estimated to collectively grow with a healthy compound annual growth rate (CAGR) of 13.20% during the forecast period of 2019 to 2025.
Owing to the world-class healthcare infrastructure in North America coupled with the significant contribution to drug development is driving the epigenetics market in the region. More than 1,919 medicines for cancer treatment are in the development stage, according to the International Federation of Pharmaceutical Manufacturers Association (IFPMA), and North America bears a substantial share of this development owing to the greater investments in the region. The rates of people suffering from cancer and cardiovascular diseases in the region have also driven the market in the region. In 2018, North America had the greatest epigenetics market share of 39%.
Epigenetics is defined as the study of heritable changes in phenotype without alteration in the DNA sequence or nucleotide sequence which can be due to DNA methylation or DNA adenine methylation, generally enabled by Streptococcus pneumonia in bacteria. This is chiefly used in diabetics wound healing or treatment of other conditions that occur due to genomic imprinting. Epigenetics market generates revenues in hospitals and research institutes.
However, the most prevalent application segment in the epigenetics market is in the services regarding epigenetics. This is much attributed to the fact that not all hospitals have their own research unit. Moreover, many hospitals have tie-ups with research institutes that provide epigenetics services, which happens to be the reason responsible for the growth opportunities in the services segment of the epigenetics market which is projected to rise with a substantial CAGR of 11.20% through to 2025.
Epigenetics Market Growth
Growing Number of People Suffering From Cardiovascular Conditions –
According to the World Health Organization, cardiovascular diseases (CVDs) is the leading cause responsible for the deaths of people, and an estimated number of 17.9 million people died from CVDs in 2016 already. Epigenetics is now considered as the foundation for the diagnosis and treatment of CDVs as it has a major cardiovascular medicine specialty in conditions such as coronary artery disease, heart failure, cardiac hypertrophy, and diabetes. The millennial lifestyle that involves the unhealthy diet, lack of exercise, cholesterol issues, and obesity are some of the factors that are makings CDVs prevalent, which is enhancing the revenues generated in the epigenetics market.
Pervading Concern Regarding Birth Defects Supporting the Market –
Birth defects have become common, expensive, and more importantly critical. In the United States alone, one in 33 babies are born with birth defects, and these defects are the leading cause of 20% of infant deaths, according to the findings by the Centers for Disease Control and Prevention (CDC). Evidently, epigenetics finds application in diagnosis and treatment of these birth defects as it helps to establish the molecular basis for the gene-environment interactions. The implementation of epigenetics in the treatment of birth defects is still under constant R&D. However, the future foresees an augmented application of epigenetics in the treatment of birth defects as a crucial driver for the epigenetics market demand growth.
General Application of Epigenetics in Drug Development –
The healthcare sector is making strides with over 7,000 number of medicines under the development stage. Apparently, the epigenetics market has paved its path into the development of the medicines. Nowadays, uncommon diseases have been proliferating through the globe, which is making the development of new medicines imperative. Development of new medicines for the cure of these uncommon diseases is leading to new horizons in the epigenetics market.
Epigenetics Market Trends:
Domestication of Animals – The epigenetics market has taken a leap into the
animal domestication. Research is under progress, and in the near future,
epigenetics will be helping to understand the domestication of various animals.
This is attributable to the fact that domestication is an evolutionary
alteration in animals, and it has roots in the genetic transformation.
In Forensic Science – DNA detection has been used in the forensic science
for quite a few years now. However, this technique doesn’t impart the results
obtained where there are a few changes in DNA that do not affect the sequence.
The application of epigenetics in forensic science is poised to observe a
Emerging Application in Chronic Kidney Diseases – The pathogenesis of
chronic kidney diseases is due to DNA methylation, aberrant histone
alterations, and changes to microRNA expressions, and epigenetics factors play
an important role in this. Epigenetics market is also booming due to the rise
in the number of kidney transplants across the globe.
The major challenge in the epigenetics market is the fact that the studies have successfully penetrated the livestock genetic analysis, but it is difficult to track the epigenetic information that changes with successive generation. Even though this constraint is not reducing the current epigenetics market size, it is limiting the lucrative expansion of the same. However, the investments made in the R&D of epigenetics are projected to gain more results. Moreover, the study of epigenetics is venturing into multiple healthcare segments which will drive opportunities for the vendors in the epigenetics market.
Epigenetics Market Key
The major players crusading for greater epigenetics market share are Illumina, Thermo Fisher Scientific, Merck Millipore, Abcam, Active Motif, Bio-Rad Laboratories, New England Biolabs, Agilent, QIAGEN, Zymo Research, PerkinElmer, and Diagenode.
Epigenetics Market Research
The base year of the study is 2018, with forecast done up to 2025. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. It also provides information on unit shipments. These provide the key market participants with the necessary business intelligence and help them understand the future of the epigenetics market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. The epigenetics market research report also analyses the application of epigenetics in research institutes and diagnostic centers.
Epigenetics Market Report:
This report also documents the demand analysis of the product based on products that include kits, reagents, and enzymes and by applications that include diagnostics and drugs).
The epigenetics market report also analyzes the major geographic regions as well as the major countries in these regions. The regions and countries covered in the study include:
Key Questions Addressed in the
Epigenetics Market Report:
Is the market demand for epigenetics growing? How long will it continue to grow and at what rate?
Which type of home security system presents the major growth opportunities?
Is there a possibility for change in the market structure over time?
Are additional developments needed for the existing product or services offerings or do the existing products meet the customer demands?
Do the key vendors look for partnerships to expand their businesses with respect to geography or product?
What are the short-term, long-term, and medium-term growth drivers for the market?
What are the short-term, medium-term, and long-term challenges for the market?
What are the short-term, medium-term, and long-term opportunities for the market
Who are the top players/companies of the market?
What are the recent innovations in the market?
How many patents have been filed by the leading players?
What are the types of patents filed by the leading players?
What is our Vision 2030 for the epigenetics market?
A Few Focus Points Of This
Research Are Given Below:
Give a deep-dive analysis of the key operational strategies with focus on the corporate structure, R&D strategies, localization strategies, production capabilities, and sales performance of various companies
Provide an overview of the product portfolio, including product planning, development, and positioning
Discuss the role of technology companies in partnerships
Explore the regional sales activities
Analyze the market size and giving the forecast for current and future global epigenetics market during the forecast 2019-2025Analyze the competitive factors, competitors’ market shares, product capabilities, and supply chain structures